Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 395


Acute stress response to a cognitive task in patients with major depressive disorder: potential metabolic and proinflammatory biomarkers.

Druzhkova T, Pochigaeva K, Yakovlev A, Kazimirova E, Grishkina M, Chepelev A, Guekht A, Gulyaeva N.

Metab Brain Dis. 2018 Dec 18. doi: 10.1007/s11011-018-0367-3. [Epub ahead of print]


Protective effect of Convolvulus pluricaulis against neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat.

Gupta GL, Fernandes J.

Biomed Pharmacother. 2019 Jan;109:1698-1708. doi: 10.1016/j.biopha.2018.11.046. Epub 2018 Nov 20.


Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression.

Lee Y, Subramaniapillai M, Brietzke E, Mansur RB, Ho RC, Yim SJ, McIntyre RS.

Ther Adv Psychopharmacol. 2018 Nov 19;8(12):337-348. doi: 10.1177/2045125318791944. eCollection 2018 Dec. Review.


Pro-inflammatory Monocyte Phenotype and Cell-Specific Steroid Signaling Alterations in Unmedicated Patients With Major Depressive Disorder.

Hasselmann H, Gamradt S, Taenzer A, Nowacki J, Zain R, Patas K, Ramien C, Paul F, Wingenfeld K, Piber D, Gold SM, Otte C.

Front Immunol. 2018 Nov 23;9:2693. doi: 10.3389/fimmu.2018.02693. eCollection 2018.


Effect of selective serotonin reuptake inhibitor on prefrontal-striatal connectivity is dependent on the level of TNF-α in patients with major depressive disorder.

Liu K, Zhao X, Lu X, Zhu X, Chen H, Wang M, Yan W, Jing L, Deng Y, Yu L, Wu H, Wen G, Sun X, Lv Z.

Psychol Med. 2018 Dec 6:1-9. doi: 10.1017/S0033291718003616. [Epub ahead of print]


Elevation of tumor necrosis factor alpha levels is associated with restless legs symptoms in clinically depressed patients.

Auvinen P, Mäntyselkä P, Koponen H, Kautiainen H, Korniloff K, Ahonen T, Vanhala M.

J Psychosom Res. 2018 Dec;115:1-5. doi: 10.1016/j.jpsychores.2018.09.008. Epub 2018 Sep 21.


(+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation.

Zhao Y, Wang Q, Jia M, Fu S, Pan J, Chu C, Liu X, Liu X, Liu Z.

J Nutr Biochem. 2018 Oct 25;64:61-71. doi: 10.1016/j.jnutbio.2018.10.006. [Epub ahead of print]


Nesfatin-1 and cortisol: potential novel diagnostic biomarkers in moderate and severe depressive disorder.

Xu YY, Ge JF, Liang J, Cao Y, Shan F, Liu Y, Yan CY, Xia QR.

Psychol Res Behav Manag. 2018 Oct 16;11:495-502. doi: 10.2147/PRBM.S183126. eCollection 2018.


Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.

Niemegeers P, de Boer P, Schuermans J, Dumont GJH, Coppens V, Spittaels K, Claes S, Sabbe BGC, Morrens M.

J Affect Disord. 2018 Nov 6;245:356-363. doi: 10.1016/j.jad.2018.11.020. [Epub ahead of print]


Chronic Psychosocial Stress in Mice Is Associated With Increased Acid Sphingomyelinase Activity in Liver and Serum and With Hepatic C16:0-Ceramide Accumulation.

Reichel M, Rhein C, Hofmann LM, Monti J, Japtok L, Langgartner D, Füchsl AM, Kleuser B, Gulbins E, Hellerbrand C, Reber SO, Kornhuber J.

Front Psychiatry. 2018 Oct 16;9:496. doi: 10.3389/fpsyt.2018.00496. eCollection 2018.


Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion.

Simões LR, Netto S, Generoso JS, Ceretta RA, Valim RF, Dominguini D, Michels M, Réus GZ, Valvassori SS, Dal-Pizzol F, Barichello T.

Pharmacol Rep. 2018 Aug 8;71(1):24-31. doi: 10.1016/j.pharep.2018.08.003. [Epub ahead of print]


Anti-Depressant-Like Effect of Sinomenine on Chronic Unpredictable Mild Stress-Induced Depression in a Mouse Model.

Liu S, Xu S, Wang Z, Guo Y, Pan W, Shen Z.

Med Sci Monit. 2018 Oct 26;24:7646-7653. doi: 10.12659/MSM.908422.


Hesperidin attenuates depression-related symptoms in mice with mild traumatic brain injury.

Kosari-Nasab M, Shokouhi G, Ghorbanihaghjo A, Abbasi MM, Salari AA.

Life Sci. 2018 Nov 15;213:198-205. doi: 10.1016/j.lfs.2018.10.040. Epub 2018 Oct 21.


2,3,5,4'-Tetrahydroxystilbene-2-O-beta-D-glucoside Reverses Stress-Induced Depression via Inflammatory and Oxidative Stress Pathways.

Jiang CY, Qin XY, Yuan MM, Lu GJ, Cheng Y.

Oxid Med Cell Longev. 2018 Sep 19;2018:9501427. doi: 10.1155/2018/9501427. eCollection 2018.


Association between baseline pro-inflammatory cytokines and brain activation during social exclusion in patients with vulnerability to suicide and depressive disorder.

Conejero I, Jaussent I, Cazals A, Thouvenot E, Mura T, Le Bars E, Guillaume S, Squalli S, Courtet P, Olié E.

Psychoneuroendocrinology. 2019 Jan;99:236-242. doi: 10.1016/j.psyneuen.2018.09.041. Epub 2018 Oct 4.


Mitogen-stimulated cell proliferation and cytokine production in major depressive disorder patients.

Lin P, Ding B, Wu Y, Dong K, Li Q.

BMC Psychiatry. 2018 Oct 12;18(1):330. doi: 10.1186/s12888-018-1906-5.


Effects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder.

Zhou R, Wang F, Zhao G, Xia W, Peng D, Mao R, Xu J, Wang Z, Hong W, Zhang C, Wang Y, Su Y, Huang J, Yang T, Wang J, Chen J, Palaniyappan L, Fang Y.

Transl Psychiatry. 2018 Oct 11;8(1):217. doi: 10.1038/s41398-018-0256-x.


The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.

El-Haggar SM, Eissa MA, Mostafa TM, El-Attar KS, Abdallah MS.

Psychother Psychosom. 2018;87(6):331-339. doi: 10.1159/000492619. Epub 2018 Sep 11.


Correlation between Depression, Posttraumatic Stress Disorder, and Inflammatory Factors in Patients with Severe Burn Injury.

Jiang D, Jiang S, Gong F, Yuan F, Zhao P, He X, Lv G, Chu X.

Am Surg. 2018 Aug 1;84(8):1350-1354.


Supplemental Content

Loading ...
Support Center